Research Progress on Histone Deacetylases Regulating Programmed Cell Death in Atherosclerosis

被引:1
|
作者
Zhou, Gang [1 ,2 ,3 ]
Liu, Yanfang [1 ,2 ,3 ]
Wu, Hui [1 ,3 ,4 ]
Zhang, Dong [1 ,2 ,3 ]
Yang, Qingzhuo [1 ,2 ,3 ]
Li, Yi [1 ,2 ,3 ]
机构
[1] China Three Gorges Univ, Inst Cardiovasc Dis, Yichang 443003, Peoples R China
[2] Yichang Cent Peoples Hosp, Dept Cent Expt Lab, Yichang 443003, Peoples R China
[3] HuBei Clin Res Ctr Ischem Cardiovasc Dis, Yichang 443003, Peoples R China
[4] Yichang Cent Peoples Hosp, Dept Cardiol, Yiling Rd 183, Yichang 443003, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Atherosclerosis; Histone deacetylases; Programmed cell death; Apoptosis; Autophagy; Pyroptosis; Ferroptosis;
D O I
10.1007/s12265-023-10444-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Histone deacetylases (HDACs) are epigenetic modifying enzyme that is closely related to chromatin structure and gene transcription, and numerous studies have found that HDACs play an important regulatory role in atherosclerosis disease. Apoptosis, autophagy and programmed necrosis as the three typical programmed cell death modalities that can lead to cell loss and are closely related to the developmental process of atherosclerosis. In recent years, accumulating evidence has shown that the programmed cell death mediated by HDACs is increasingly important in the pathophysiology of atherosclerosis. This paper first gives a brief overview of HDACs, the mechanism of programmed cell death, and their role in atherosclerosis, and then further elaborates on the role and mechanism of HDACs in regulating apoptosis, autophagy, and programmed necrosis in atherosclerosis, respectively, to provide new effective measures and theoretical basis for the prevention and treatment of atherosclerosis.
引用
收藏
页码:308 / 321
页数:14
相关论文
共 50 条
  • [1] Research Progress on Histone Deacetylases Regulating Programmed Cell Death in Atherosclerosis
    Gang Zhou
    Yanfang Liu
    Hui Wu
    Dong Zhang
    Qingzhuo Yang
    Yi Li
    Journal of Cardiovascular Translational Research, 2024, 17 : 308 - 321
  • [2] The Function, Regulation and Mechanism of Programmed Cell Death of Macrophages in Atherosclerosis
    Liu, Chang
    Jiang, Zecheng
    Pan, Zhongjie
    Yang, Liang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [3] Research progress on morphology and mechanism of programmed cell death
    Chen, Yao
    Li, Xiaohua
    Yang, Minfeng
    Liu, Song-Bai
    CELL DEATH & DISEASE, 2024, 15 (05):
  • [4] Research Progress on Micro(nano)plastic-Induced Programmed Cell Death Associated with Disease Risks
    Liu, Huanpeng
    Li, Huiqi
    Chen, Ting
    Yu, Fan
    Lin, Qizhuan
    Zhao, Haiyang
    Jin, Libo
    Peng, Renyi
    TOXICS, 2024, 12 (07)
  • [5] Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma
    Ma, Meng
    Fei, Xifeng
    Jiang, Dongyi
    Chen, Hanchun
    Xie, Xiangtong
    Wang, Zhimin
    Huang, Qiang
    ONCOLOGY REVIEWS, 2024, 18
  • [6] Oxidative Stress-Mediated Programmed Cell Death: a Potential Therapy Target for Atherosclerosis
    Chen, Yuwu
    Luo, Xing
    Xu, Biyi
    Bao, Xiaoyi
    Jia, Haibo
    Yu, Bo
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (04) : 819 - 832
  • [7] Melatonin as a treatment for atherosclerosis: focus on programmed cell death, inflammation and oxidative stress
    Reza Asemi
    Elham Omidi Najafabadi
    Zahra Mahmoudian
    Russel J. Reiter
    Mohammad Ali Mansournia
    Zatollah Asemi
    Journal of Cardiothoracic Surgery, 20 (1)
  • [8] Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis
    Long, Haijiao
    Yu, Yulu
    Ouyang, Jie
    Lu, Hongwei
    Zhao, Guojun
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [9] The biology of YAP in programmed cell death
    Yifan Cheng
    Misha Mao
    Yong Lu
    Biomarker Research, 10
  • [10] The biology of YAP in programmed cell death
    Cheng, Yifan
    Mao, Misha
    Lu, Yong
    BIOMARKER RESEARCH, 2022, 10 (01)